Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies ...

Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...

NIH-funded research suggests AI-powered tool could streamline diagnoses and unveil early markers for chronic disease. March 8, 2026 – National Institutes of Health (NIH) released the following: A ...

NEW YORK, Feb. 10, 2026 /PRNewswire/ -- ObvioHealth and Oracle Health and Life Sciences today announced that ObvioGo® is now directly integrated with Oracle Health and Life Sciences Clinical One Data ...

NYU Langone Health orthopedic experts are presenting their latest clinical findings and research discoveries at the 2026 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), held ...

Strategic leadership changes -- Eran Ophir became CEO in September 2025, with Anat Cohen-Dayag transitioning to Executive Chair to enhance operational focus and strategic continuity.

Three academic perspectives offer insights on the persistent misconceptions about artificial intelligence in healthcare.

Former assistant professor of epidemiology, immunology, and infectious disease at the Harvard T.H. Chan School of Public Health and pathology at Harvard Medical School and Brigham and Women’s Hospital ...

Full year revenue growth of 97% driven by strong performance in molecular profiling servicesExpects full year 2026 revenue to be in the range of $1.0 ...

Tim Coleman has held positions within information technology at Lilly in research and development, sales and marketing, manufacturing, and human resources.

About Insilico Medicine: Insilico Medicine is a clinical-stage biotechnology company using AI for drug development across cancer, fibrosis, immunity, central nervous system diseases, and aging-related ...